Vol. 64 No. 1 (2004)

Articles

Nigel Greig, Tony Giordano, Xiaoxiang Zhu, Qian-sheng Yu, Tracy Perry, Harold Holloway, Arnold Brossi, Jack Rogers, Kumar Sambamurti, Debomoy Lahiri
1-9
Thalidomide-based TNF-α inhibitors for neurodegenerative diseases
PDF
DOI: https://doi.org/10.55782/ane-2004-1486
Rudy Castellani, George Perry, Mark Smith
11-17
Prion disease and Alzheimer's disease: pathogenic overlap
PDF
DOI: https://doi.org/10.55782/ane-2004-1487
Cezary Zekanowski, Dorota Religa, Caroline Graff, Slawomir Filipek, Jacek Kuznicki
19-31
Genetic aspects of Alzheimer's disease
PDF
DOI: https://doi.org/10.55782/ane-2004-1488
Alberto Gómez-Ramos, Mark Smith, George Perry, Jesús Avila
33-39
Tau phosphorylation and assembly
PDF
DOI: https://doi.org/10.55782/ane-2004-1489
Katarzyna Trześniewska, Maria Brzyska, Danek Elbaum
41-52
Neurodegenerative aspects of protein aggregation
PDF
DOI: https://doi.org/10.55782/ane-2004-1490
Tomasz Sobów, Marcin Flirski, Paweł Liberski
53-70
Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease
PDF
DOI: https://doi.org/10.55782/ane-2004-1491
Alexei Koudinov, Temirbolat Berezov
71-79
Alzheimer's amyloid-beta (Aβ) is an essential synaptic protein, not neurotoxic junk
PDF
DOI: https://doi.org/10.55782/ane-2004-1492
Michael Marlatt, Hyoung-gon Lee, George Perry, Mark Smith, Xiongwei Zhu
81-87
Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease
PDF
DOI: https://doi.org/10.55782/ane-2004-1493
Hyoung-gon Lee, Xiongwei Zhu, Michael O'Neill, Kate Webber, Gemma Casadesus, Michael Marlatt, Arun Raina, George Perry, Mark Smith
89-98
The role of metabotropic glutamate receptors in Alzheimer's disease
PDF
DOI: https://doi.org/10.55782/ane-2004-1494
Takeshi Kihara, Shun Shimohama
99-105
Alzheimer's disease and acetylcholine receptors
PDF
DOI: https://doi.org/10.55782/ane-2004-1495
Arun Raina, Xiongwei Zhu, Mark Smith
107-112
Alzheimer's disease and the cell cycle
PDF
DOI: https://doi.org/10.55782/ane-2004-1496
Kate Webber, Richard Bowen, Gemma Casadesus, George Perry, Craig Atwood, Mark Smith
113-118
Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection
PDF
DOI: https://doi.org/10.55782/ane-2004-1497